ArticleScientific reports2025
A novel residual network based on multidimensional attention and pinwheel convolution for brain tumor classification.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Early and accurate brain tumor classification is vital for clinical diagnosis and treatment. Although Convolutional Neural Networks (CNNs) are widely used in medical image analysis, they often struggle to focus on critical information adequately and have limited feature extraction capabilities. To address these challenges, this study proposes a novel Residual Network based on Multi-dimensional Attention and Pinwheel Convolution (Res-MAPNet) for Magnetic Resonance Imaging (MRI) based brain tumor classification. Res-MAPNet is developed on two key modules: the Coordinated Local Importance Enhancement Attention (CLIA) module and the Pinwheel-Shaped Attention Convolution (PSAConv) module. CLIA combines channel attention, spatial attention, and direction-aware positional encoding to focus on lesion areas. PSAConv enhances spatial feature perception through asymmetric padding and grouped convolution, expanding the receptive field for better feature extraction. The proposed model classifies two publicly brain tumor datasets into glioma, meningioma, pituitary tumor, and no tumor. The experimental results show that the proposed model achieves 99.51% accuracy in the three-classification task and 98.01% accuracy in the four-classification task, better than the existing mainstream models. Ablation studies validate the effectiveness of CLIA and PSAConv, which are 4.41% and 4.45% higher than the ConvNeXt baseline, respectively. This study provides an efficient and robust solution for brain tumor computer-aided diagnosis systems with potential for clinical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.